FilingReader Intelligence
Shenzhen New Industries announces strong 2024 results, share pledge
April 14, 2025 at 07:13 AM UTC•By FilingReader AI
Shenzhen New Industries Biomedical Engineering (SZSE:300832) announced preliminary unaudited results for 2024, showcasing robust growth. Revenue increased by 15.41% to CNY453,540.45 thousand, while net profit attributable to shareholders rose by 10.57% to CNY182,845.66 thousand. Basic earnings per share also saw a 10.53% increase, reaching CNY2.3271.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
SZSE:300832•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Shenzhen New Industries Biomedical Engineering publishes news
Free account required • Unsubscribe anytime